CCL5 and COVID-19: Bruce et al. reported a considerable increase of CCL5 (RANTES) and plasma IL-6, decreased CD8+ T-cell levels, and SARS-CoV-2 plasma viremia in 10 terminally-ill, critical COVID-19 cases.